Cerity Partners LLC Trims Position in CVS Health Co. (NYSE:CVS)

Cerity Partners LLC lowered its position in CVS Health Co. (NYSE:CVS - Free Report) by 14.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 617,980 shares of the pharmacy operator's stock after selling 107,360 shares during the quarter. Cerity Partners LLC's holdings in CVS Health were worth $38,859,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the business. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health during the 3rd quarter worth about $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter worth approximately $31,000. Reston Wealth Management LLC acquired a new position in CVS Health in the third quarter valued at approximately $32,000. First Community Trust NA grew its position in shares of CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock worth $33,000 after buying an additional 302 shares during the period. Finally, Kathleen S. Wright Associates Inc. acquired a new position in shares of CVS Health during the 3rd quarter valued at $33,000. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Up 1.6 %

Shares of NYSE CVS traded up $0.91 during trading on Friday, reaching $58.01. The company had a trading volume of 11,153,900 shares, compared to its average volume of 12,620,673. The stock has a market cap of $73.00 billion, a PE ratio of 14.72, a P/E/G ratio of 0.96 and a beta of 0.55. The business's 50-day moving average is $59.21 and its 200 day moving average is $58.61. CVS Health Co. has a 12-month low of $52.71 and a 12-month high of $83.25. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion for the quarter, compared to analysts' expectations of $92.72 billion. During the same quarter in the prior year, the company posted $2.21 earnings per share. The business's revenue for the quarter was up 6.3% on a year-over-year basis. As a group, equities analysts forecast that CVS Health Co. will post 5.43 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.59%. CVS Health's dividend payout ratio (DPR) is presently 67.51%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CVS. Barclays lowered their price objective on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a report on Thursday, November 7th. StockNews.com lowered CVS Health from a "hold" rating to a "sell" rating in a report on Thursday, November 14th. Wells Fargo & Company upgraded CVS Health from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $60.00 to $66.00 in a research note on Monday, November 18th. UBS Group upped their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a research note on Thursday, November 7th. Finally, TD Cowen raised shares of CVS Health from a "hold" rating to a "buy" rating and raised their price target for the company from $59.00 to $85.00 in a research report on Friday, October 4th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $72.28.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.